Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, R. J.
Right arrow Articles by Duncan, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, R. J.
Right arrow Articles by Duncan, L. J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 7, Issue 5 479-480, Copyright © 1984 by American Diabetes Association

ARTICLES

Diabetic lipohypertrophy delays insulin absorption

RJ Young, WJ Hannan, BM Frier, JM Steel and LJ Duncan

The effect of lipohypertrophy at injection sites on insulin absorption has been studied in 12 insulin-dependent diabetic patients. The clearance of 125I-insulin from sites with lipohypertrophy was significantly slower than from complementary nonhypertrophied sites (% clearance in 3 h, 43.8 +/- 3.5 +/- SEM) control; 35.3 +/- 3.9 lipohypertrophy, P less than 0.05). The degree of the effect was variable but sufficient in several patients to be of clinical importance. Injection-site lipohypertrophy is another factor that modifies the absorption of subcutaneously injected insulin.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
J. J.F. McVean, J. C. Eickhoff, and M. J. MacDonald
Factors Correlating With Improved A1C in Children Using Continuous Subcutaneous Insulin Infusion
Diabetes Care, October 1, 2007; 30(10): 2499 - 2500.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
U.-B. Johansson, S. Amsberg, L. Hannerz, R. Wredling, U. Adamson, H. J. Arnqvist, and P.-E. Lins
Impaired Absorption of Insulin Aspart From Lipohypertrophic Injection Sites
Diabetes Care, August 1, 2005; 28(8): 2025 - 2027.
[Full Text] [PDF]

Home page
 BMJHome page
T. A Chowdhury and V. Escudier
Poor glycaemic control caused by insulin induced lipohypertrophy
BMJ, August 16, 2003; 327(7411): 383 - 384.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
T. Lindstrom, C. A. Hedman, and H. J. Arnqvist
Use of a Novel Double-Antibody Technique to Describe the Pharmacokinetics of Rapid-Acting Insulin Analogs
Diabetes Care, June 1, 2002; 25(6): 1049 - 1054.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
L. Monaco, G. Geffken, and J. H. Silverstein
Accuracy of Injection Site Identification Among Children with Insulin Dependent Diabetes Mellitus: A Comparison of Traditional and New Visual Aids
Clinical Pediatrics, April 1, 1996; 35(4): 191 - 197.
[Abstract] [PDF]

Home page
 The Diabetes EducatorHome page
V. Peragallo-Dittko
Aspiration of the Subcutaneous Insulin Injection: Clinical Evaluation of Needle Size and Amount of Subcutaneous Fat
The Diabetes Educator, January 1, 1995; 21(4): 291 - 296.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1984 by the American Diabetes Association.